Press release
Ipatasertib Market on Track for Strong Growth, Estimated to Grow at 13.2% CAGR Through 2029
Ipatasertib Market
What Is the Expected CAGR for the Ipatasertib Market Through 2025?
The market for ipatasertib has witnessed swift expansion in previous years. It is projected to escalate from a value of $0.76 billion in 2024 to $0.86 billion in 2025, experiencing a compound annual growth rate (CAGR) of 13.6%. Several factors have contributed to this growth in the historic timeframe, such as the rising global occurrence of cancer, escalated number of prostate cancer incidents, an increase in the volume of clinical trials, augmented investment in cancer research and development, and an emerging inclination towards personalized medicine.
What's the Projected Size of the Global Ipatasertib Market by 2029?
In the coming years, the ipatasertib market is set to experience substantial expansion, reaching a value of $1.42 billion in 2029 with a compound annual growth rate (CAGR) of 13.2%. This surge in the forecast period is a result of growing government support, an increase in the demand for immunomodulatory therapies, the escalating trend of precision medicine, heightened investment in healthcare services, and an uptick in healthcare spending. During the forecast period, key trends may include improvements in targeted treatment, breakthroughs in biotechnology and pharmaceutical research, incorporation of computational biology technologies, and the invention of novel therapeutic applications for ipatasertib.
View the full report here:
https://www.thebusinessresearchcompany.com/report/ipatasertib-global-market-report
Top Growth Drivers in the Ipatasertib Industry: What's Accelerating the Market?
The ipatasertib market is expected to expand due to the escalating prevalence of cancer. Typically, cancer encompasses a range of illnesses where cells within the body proliferate abnormally and unfetteredly. Increased incidences of this disease can be traced back to harmful lifestyle practices like poor nutrition, smoking, sedentary behavior, and overconsumption of alcohol. Ipatasertib bolsters cancer treatment methods by acting on the PI3K/AKT signalling pathway, hence it is potent in hampering tumor proliferation and growth. This drug successfully curbs cancer cell survivability and opposition to therapy, thus enhancing therapy outcomes and patient prognosis. To exemplify, the National Health Service, a department of the UK government, indicated a 5% uptick in fresh cancer diagnoses in October 2024: from 329,664 in 2021 to 346,217 in 2022, translating to roughly 948 cases daily. Thus, cancer's burgeoning prevalence is fueling the ipatasertib market's growth. The upswing in preference for personalized medicine is likely to catapult the growth of the ipatasertib market. Personalized medicine is a medical model where treatment and prevention strategies are custom-fit to a person's unique genetic profile, lifestyle, and surroundings. The surge in the adoption of personalized medicine is largely due to leaps and bounds in genomics, enabling exact pinpointing of genetic variations and tailoring treatments uniquely to individuals. Ipatasertib augments personalized medicine by acting on the PI3K/AKT signaling pathway, thus making cancer treatment more bespoke to individual patient tumor profiles. It enhances therapeutic impact by addressing certain genetic and molecular features, abating treatment resistance and enhancing patient outcomes. For example, the Personalized Medicine Coalition (PMC), a nonprofit based in the US, reported that the U.S. Food and Drug Administration (FDA) gave the green light to 26 fresh personalized medicines in 2023, a marked upturn from the 12 authorized in 2022. Thus, the spiking preference for personalized medicine is spurring the growth of the ipatasertib market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28253&type=smp
What Are the Main Segments in the Ipatasertib Market?
The ipatasertib market covered in this report is segmented as
1) By Indication: Prostate Cancer, Breast Cancer, Other Cancers
2) By Dosage Form: Tablets, Capsules, Other Dosages
3) By Route Of Administration: Oral, Intravenous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Prostate Cancer: Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Non-Metastatic Prostate Cancer
2) By Breast Cancer: Triple-Negative Breast Cancer (TNBC), Hormone Receptor-Positive Or Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer, Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
3) By Other Cancers: Ovarian Cancer, Gastric Cancer, Pancreatic Cancer, Colorectal Cancer, Lung Cancer
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28253&type=smp
Which Top Companies are Driving Growth in the Ipatasertib Market?
Major companies operating in the ipatasertib market are F. Hoffmann-La Roche AG, Abcam plc, Cayman Chemical Company Inc., Selleck Chemicals LLC, ChemScene LLC, Creative Biolabs Inc., TargetMol Chemicals Inc., MedChemExpress LLC, BOC Sciences Inc., Adooq Bioscience LLC, Axon Medchem BV, MedKoo Biosciences Inc., Ambeed Inc., InvivoChem LLC, Focus Biomolecules Inc., and ApexBio Technology LLC.
Which Regions Will Dominate the Ipatasertib Market Through 2029?
North America was the largest region in the ipatasertib market in 2024. The regions covered in ipatasertib report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28253
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ipatasertib Market on Track for Strong Growth, Estimated to Grow at 13.2% CAGR Through 2029 here
News-ID: 4213401 • Views: …
More Releases from The Business Research Company
Top Market Shifts Transforming the In Silico Protein Design Market Landscape: Ke …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the In Silico Protein Design Market Through 2025?
The market size for in silico protein design has seen a significant increase in recent years, expanding from $1.54 billion in 2024 to $1.87 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Rising Prevalence Of Musculoskeletal Disorders Fueling The Growth Of The Market …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Heated Shoulder Wrap Market Through 2025?
The market size for heated shoulder wraps has seen a swift expansion in recent years. Its growth is expected to increase from $1.12 billion in 2024 to $1.24 billion in 2025, with a compound annual growth…
2025-2034 Haptic Virtual Reality (VR) Fitness Suit Market Evolution: Disruptions …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Haptic Virtual Reality (VR) Fitness Suit Market Through 2025?
The market size for the haptic virtual reality (VR) fitness suit has experienced significant growth over the past few years. The market is anticipated to increase from $1.25 billion in 2024 to $1.60…
Soaring Demand Set to Propel Gene-Circuit Cell Therapy Market to $2.95 Billion b …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Gene-Circuit Cell Therapy Market Through 2025?
The market for gene-circuit cell therapy has seen significant expansion in recent times. The market, currently valued at $1.14 billion in 2024, is projected to increase to $1.38 billion in 2025, boasting a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
